<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Vestnik dermatologii i venerologii</journal-id><journal-title-group><journal-title xml:lang="en">Vestnik dermatologii i venerologii</journal-title><trans-title-group xml:lang="ru"><trans-title>Вестник дерматологии и венерологии</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0042-4609</issn><issn publication-format="electronic">2313-6294</issn><publisher><publisher-name xml:lang="en">Rossijskoe Obschestvo Dermatovenerologov i Kosmetologov</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1390</article-id><article-id pub-id-type="doi">10.25208/vdv1390</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>ORIGINAL STUDIES</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>НАУЧНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">The use of 585 and 1064 nm laser for the treatment of basal cell skin cancer</article-title><trans-title-group xml:lang="ru"><trans-title>Использование лазерного излучения с длиной волны 585 и 1064 нм для лечения базальноклеточного рака кожи</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6132-5632</contrib-id><contrib-id contrib-id-type="spin">1149-2097</contrib-id><name-alternatives><name xml:lang="en"><surname>Saytburkhanov</surname><given-names>Rifat R.</given-names></name><name xml:lang="ru"><surname>Сайтбурханов</surname><given-names>Рифат Рафаилевич</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Dermatovenereologist</p></bio><bio xml:lang="ru"><p>врач-дерматовенеролог</p></bio><email>rifat03@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3662-9954</contrib-id><contrib-id contrib-id-type="spin">8721-9424</contrib-id><name-alternatives><name xml:lang="en"><surname>Kondrakhina</surname><given-names>Irina N.</given-names></name><name xml:lang="ru"><surname>Кондрахина</surname><given-names>Ирина Никифоровна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Cand. (Sci.) Med</p></bio><bio xml:lang="ru"><p>к.м.н.</p></bio><email>kondrakhina77@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4169-4128</contrib-id><contrib-id contrib-id-type="spin">7634-5521</contrib-id><name-alternatives><name xml:lang="en"><surname>Plakhova</surname><given-names>Xenia I.</given-names></name><name xml:lang="ru"><surname>Плахова</surname><given-names>Ксения Ильинична</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Dr. Sci. (Med.)</p></bio><bio xml:lang="ru"><p>д.м.н.</p></bio><email>plahova@cnikvi.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7625-0503</contrib-id><contrib-id contrib-id-type="spin">8771-4990</contrib-id><name-alternatives><name xml:lang="en"><surname>Kubanov</surname><given-names>Alexey A.</given-names></name><name xml:lang="ru"><surname>Кубанов</surname><given-names>Алексей Алексеевич</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Dr. Sci. (Med.), Professor, Academician of the Russian Academy of Sciences</p></bio><bio xml:lang="ru"><p>д.м.н., профессор, академик РАН</p></bio><email>alex@cnikvi.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">State Research Center of Dermatovenereology and Cosmetology</institution></aff><aff><institution xml:lang="ru">Государственный научный центр дерматовенерологии и косметологии</institution></aff></aff-alternatives><pub-date date-type="preprint" iso-8601-date="2023-01-16" publication-format="electronic"><day>16</day><month>01</month><year>2023</year></pub-date><pub-date date-type="pub" iso-8601-date="2023-01-27" publication-format="electronic"><day>27</day><month>01</month><year>2023</year></pub-date><volume>98</volume><issue>6</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>89</fpage><lpage>100</lpage><history><date date-type="received" iso-8601-date="2022-10-18"><day>18</day><month>10</month><year>2022</year></date><date date-type="accepted" iso-8601-date="2022-12-29"><day>29</day><month>12</month><year>2022</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2023, Saytburkhanov R.R., Kondrakhina I.N., Plakhova X.I., Kubanov A.A.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2023, Сайтбурханов Р.Р., Кондрахина И.Н., Плахова К.И., Кубанов А.А.</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="en">Saytburkhanov R.R., Kondrakhina I.N., Plakhova X.I., Kubanov A.A.</copyright-holder><copyright-holder xml:lang="ru">Сайтбурханов Р.Р., Кондрахина И.Н., Плахова К.И., Кубанов А.А.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://vestnikdv.ru/jour/article/view/1390">https://vestnikdv.ru/jour/article/view/1390</self-uri><abstract xml:lang="en"><p><bold>Background.</bold> Basal cell skin cancer is the most common malignant epithelial skin neoplasm in fair-skinned people and accounts for two-thirds of all skin cancers in this population. Tumor lesions have a supporting vascular network that serves as a target for vascular selective lasers.</p> <p><bold>Aims.</bold> To assess the effects of laser radiation at a wavelength of 585 and 1064 nm on the vasculature of various forms of basal cell skin cancer using dermatoscopy and in vivo confocal microscopy.</p> <p><bold>Materials and methods.</bold> The study included 20 patients with 20 lesions of histologically confirmed basal cell skin cancer treated with a pulsed dye laser (wavelength 585 nm) and a long-pulse neodymium laser (wavelength 1064 nm) in the conditions of the consultative and diagnostic center of the Federal State Budgetary Institution “GNTSDK” of the Ministry of Health RF in the period from 2021 to 2022. The effectiveness of therapy was assessed using non-invasive methods for examining the skin.</p> <p><bold>Results.</bold> According to the results of the two-year follow-up period, 100% effectiveness of therapy in both groups is noted, in 2 patients treated with a neodymium laser, the formation of hypertrophic scars in the treatment area is noted.</p> <p><bold>Conclusions.</bold> Treatment of patients with basal cell skin cancer with selective vascular lasers may be an effective treatment option. Additional studies with a larger sample of observations and a long monitoring period are needed to confirm the effectiveness of this treatment method.</p></abstract><trans-abstract xml:lang="ru"><p><bold>Обоснование.</bold> Базальноклеточный рак кожи — самое распространенное злокачественное эпителиальное новообразование кожи у светлокожих людей, которое составляет около двух третей всех случаев рака кожи у данной популяции. Очаги опухоли имеют поддерживающую сосудистую сеть, которая служит мишенью для сосудистых селективных лазеров.</p> <p><bold>Цель исследования.</bold> Оценить эффекты, оказываемые лазерным излучением с длиной волны 585 и 1064 нм на сосудистую сеть различных форм базальноклеточного рака кожи, с помощью дерматоскопического и прижизненного конфокально-микроскопического исследования.</p> <p><bold>Методы.</bold> В исследование было включено 20 пациентов с 20 очагами гистологически подтвержденного базальноклеточного рака кожи, получавших лечение с применением импульсного лазера на красителе (длина волны 585 нм) и длинноимпульсного неодимового лазера (длина волны 1064 нм) в условиях консультативно-диагностического центра ФГБУ «ГНЦДК» Минздрава РФ в период с 2021 по 2022 г. Эффективность терапии оценивалась с помощью неинвазивных методов исследования кожного покрова.</p> <p><bold>Результаты.</bold> По результатам двухлетнего периода наблюдения отмечается 100% эффективность терапии в обеих группах, у 2 пациентов, получавших лечение с помощью неодимового лазера, выявлено формирование гипертрофических рубцов в зоне лечения.</p> <p><bold>Заключение.</bold> Лечение пациентов с базальноклеточным раком кожи с помощью селективных сосудистых лазеров может быть эффективным вариантом терапии. Необходимы дополнительные исследования с большей выборкой наблюдений и длительным периодом мониторинга для подтверждения эффективности данного метода лечения.</p></trans-abstract><kwd-group xml:lang="en"><kwd>basal cell carcinoma</kwd><kwd>pulsed dye laser</kwd><kwd>neodim laser</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>базальноклеточный рак кожи</kwd><kwd>пульсирующий лазер на красителе</kwd><kwd>неодимовый лазер</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Кубанов А.А., Кондрахина И.Н., Плахова К.И., Сайтбурханов Р.Р. Современное представление о патогенезе базальноклеточного рака кожи. Вестник дерматологии и венерологии. 2021;97(5):38–51 [Kubanov AA, Kondrahina IN, Plahova KI, Sajtburhanov RR. Modern understanding of the pathogenesis of basal cell skin cancer. Vestnik dermatologii i venerologii. 2021;97(5):38–51 (In Russ.)] doi: 10.25208/vdv1277</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Ionescu DN, Arida M, Jukic DM. Metastatic basal cell carcinoma: four case reports, review of literature, and immunohistochemical evaluation. Arch Pathol Lab Med. 2006;130(1):45–51. doi: 10.5858/2006-130-45-MBCCFC</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Richarz NA, Boada A, Carrascosa JM. Angiogenesis in Dermatology — Insights of Molecular Mechanisms and Latest Developments. Actas Dermosifiliogr. 2017;108(6):515–523. doi: 10.1016/j.ad.2016.12.001</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Veikkola T, Karkkainen M, Claesson-Welsh L, Alitalo K. Regulation of angiogenesis via vascular endothelial growth factor receptors. Cancer Res. 2000;60(2):203–212.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst. 1990;82(1):4–6. doi: 10.1093/jnci/82.1.4</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Folkman J, Watson K, Ingber D, Hanahan D. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature. 1989;339(6219):58–61. doi: 10.1038/339058a0</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Srivastava A, Laidler P, Davies RP, Horgan K, Hughes LE. The prognostic significance of tumor vascularity in intermediate-thickness (0.76–4.0 mm thick) skin melanoma. A quantitative histologic study. Am J Pathol. 1988;133(2):419–423.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Wang Z, Dabrosin C, Yin X, Fuster MM, Arreola A, Rathmell WK, et al. Broad targeting of angiogenesis for cancer prevention and therapy. Semin Cancer Biol. 2015;35 Suppl(Suppl):S224–S243. doi: 10.1016/j.semcancer.2015.01.001</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Winter J, Kneitz H, Bröcker EB. Blood vessel density in Basal cell carcinomas and benign trichogenic tumors as a marker for differential diagnosis in dermatopathology. J Skin Cancer. 2011;2011:241382. doi: 10.1155/2011/241382.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Bowden J, Brennan PA, Umar T, Cronin A. Expression of vascular endothelial growth factor in basal cell carcinoma and cutaneous squamous cell carcinoma of the head and neck. J Cut Pathol. 2002;29(10):585–589. doi: 10.1034/j.1600-0560.2002.291003.x</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Lupu M, Caruntu C, Ghita MA, Voiculescu V, Voiculescu S, Rosca AE, et al. Gene Expression and Proteome Analysis as Sources of Biomarkers in Basal Cell Carcinoma. Dis Markers. 2016;2016:9831237. doi: 10.1155/2016/9831237</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Verduzco-Martínez AP, Quiñones-Venegas R, Guevara-Gutiérrez E, Tlacuilo-Parra A. Correlation of dermoscopic findings with histopathologic variants of basal cell carcinoma. Int J Dermatol. 2013;52(6):718–721. doi: 10.1111/j.1365-4632.2012.05816.x</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Jain RK. Determinants of tumor blood flow: a review. Cancer Res. 1988;48(10):2641–2658.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Altamura D, Menzies SW, Argenziano G, Zalaudek I, Soyer HP, Sera F, et al. Dermatoscopy of basal cell carcinoma: morphologic variability of global and local features and accuracy of diagnosis. J Am Acad Dermatol. 2010;62(1):67–75. doi: 10.1016/j.jaad.2009.05.035</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Puig S, Cecilia N, Malvehy J. Dermoscopic criteria and basal cell carcinoma. G Ital Dermatol Venereol. 2012;147(2):135–140.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Argenziano G, Zalaudek I, Corona R, Sera F, Cicale L, Petrillo G, et al. Vascular structures in skin tumors: a dermoscopy study. Arch Dermatol. 2004;140(12):1485–1489. doi: 10.1001/archderm.140.12.1485</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Trigoni A, Lazaridou E, Apalla Z, Vakirlis E, Chrysomallis F, Varytimiadis D, et al. Dermoscopic features in the diagnosis of different types of basal cell carcinoma: a prospective analysis. Hippokratia. 2012;16(1):29–34.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Lallas A, Apalla Z, Ioannides D, Argenziano G, Castagnetti F, Moscarella E, et al. Dermoscopy in the diagnosis and management of basal cell carcinoma. Future Oncol. 2015;11(22):2975–2984. doi: 10.2217/fon.15.193</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Liebman TN, Jaimes-Lopez N, Balagula Y, Rabinovitz HS, Wang SQ, Dusza SW, et al. Dermoscopic features of basal cell carcinomas: differences in appearance under non-polarized and polarized light. Dermatol Surg. 2012;38(3):392–399. doi: 10.1111/j.1524-4725.2011.02205.x</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Popadić M. Statistical evaluation of dermoscopic features in basal cell carcinomas. Dermatol Surg. 2014;40(7):718–724. doi: 10.1111/dsu.0000000000000031</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Malvehy J, Hanke-Martinez M, Costa J, Salerni G, Carrera C, Puig S. Semiology and pattern analysis in nonmelanocytic lesions. In: Reflectance Confocal Microscopy for Skin. Berlin; Heidelberg: Springer; 2012. P. 239–252.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Gerger A, Koller S, Weger W, Richtig E, Kerl H, Samonigg H, et al. Sensitivity and specificity of confocal laser-scanning microscopy for in vivo diagnosis of malignant skin tumors. Cancer. 2006;107(1):193–200. doi: 10.1002/cncr.21910</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Angara K, Borin TF, Arbab AS. Vascular Mimicry: A Novel Neovascularization Mechanism Driving Anti-Angiogenic Therapy (AAT) Resistance in Glioblastoma. Transl Oncol. 2017;10(4):650–660. doi: 10.1016/j.tranon.2017.04.007</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Chung AS, Ferrara N. Developmental and pathological angiogenesis. Annu Rev Cell Dev Biol. 2011;27:563–584. doi: 10.1146/annurev-cellbio-092910-154002</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Shah SM, Konnikov N, Duncan LM, Tannous ZS. The effect of 595 nm pulsed dye laser on superficial and nodular basal cell carcinomas. Lasers Surg Med. 2009;41(6):417–422. doi: 10.1002/lsm.20787</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Konnikov N, Avram M, Jarell A, Tannous Z. Pulsed dye laser as a novel non-surgical treatment for basal cell carcinomas: response and follow up 12–21 months after treatment. Lasers Surg Med. 2011;43(2):72–78. doi: 10.1002/lsm.21035</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Tran HT, Lee RA, Oganesyan G, Jiang SB. Single treatment of non-melanoma skin cancers using a pulsed-dye laser with stacked pulses. Lasers Surg Med. 2012;44(6):459–467. doi: 10.1002/lsm.22032</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>El-Tonsy MH, El-Domyati MM, El-Sawy AE, El-Din WH, Anbar Tel-D, Raouf HA. Continuous-wave Nd:Yag laser hyperthermia: a successful modality in treatment of basal cell carcinoma. Dermatol Online J. 2004;10(2):3.</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Moskalik K, Kozlow A, Demin E, Boiko E. Powerful neodymium laser radiation for the treatment of facial carcinoma: 5 year follow-up data. Eur J Dermatol. 2010;20(6):738–742. doi: 10.1684/ejd.2010.1055</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Markowitz O, Bressler MY. Combining Nd:YAG laser with optical coherence tomography for nonsurgical treatment of basal cell carcinoma. Lasers Surg Med. 2022;54(1):105–112. doi: 10.1002/lsm.23455</mixed-citation></ref></ref-list></back></article>
